• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性乳腺癌患者肿瘤芽生与已知临床病理、组织形态学及激素受体状态的相关性

Correlation of Tumor Budding With Known Clinicopathological, Histomorphological and Hormonal Receptor Status in Patients With Invasive Breast Carcinoma.

作者信息

Rathod Gunvanti B, Desai Killol N, Shrivastava Atul, Maru Alpeshkumar M

机构信息

Pathology, AIl India Institute of Medical Sciences (AIIMS), Hyderabad, IND.

Pathology, Nootan Medical College & Research Centre, Visnagar, IND.

出版信息

Cureus. 2022 Sep 26;14(9):e29637. doi: 10.7759/cureus.29637. eCollection 2022 Sep.

DOI:10.7759/cureus.29637
PMID:36320968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9606632/
Abstract

: Tumor blossoming may be a predictive indicator for a variety of cancers. At the invasive origin of the tumor, cells get detached from the original tumor mass. : Studying breast cancer tumor budding, as well as its link to other prognostic indicators, such as clinicopathological features and hormone receptor status, will be the focus of this study. : Over six years, 110 cases of invasive breast cancer were examined. Ten high-power fields were used to analyze H&E-stained slices for tumor sprouting. It was determined that the tumor buds were divided into low and high grades. Tumor budding and other prognostic factors were compared using the chi-square test. It was considered significant if the p-value was less than or equal to 0.05. : There were 110 cases of invasive ductal carcinoma, which accounts for more than half of the total cases (88.18%). A total of 144 tumors were present, of which 74 displayed strong budding and 36 displayed poor budding. A correlation between tumor budding and tumor size, lymph node metastasis, and tumor stage is statistically significant (P = 0.0099). : Tumor budding in breast cancer is an easily visible in microscopy, novel prognostic indicator. A new prognostic element may be added to the reporting process.

摘要

肿瘤芽生可能是多种癌症的预测指标。在肿瘤的侵袭起源处,细胞从原始肿瘤块上脱离。:研究乳腺癌肿瘤芽生及其与其他预后指标(如临床病理特征和激素受体状态)的联系,将是本研究的重点。:在六年多的时间里,对110例浸润性乳腺癌病例进行了检查。使用十个高倍视野分析苏木精-伊红染色切片中的肿瘤芽生情况。确定肿瘤芽分为低级别和高级别。使用卡方检验比较肿瘤芽生和其他预后因素。如果p值小于或等于0.05,则认为具有显著性。:有110例浸润性导管癌,占总病例数的一半以上(88.18%)。共有144个肿瘤,其中74个显示强烈芽生,36个显示芽生不良。肿瘤芽生与肿瘤大小、淋巴结转移和肿瘤分期之间的相关性具有统计学意义(P = 0.0099)。:乳腺癌中的肿瘤芽生在显微镜下很容易观察到,是一种新的预后指标。可以在报告过程中添加一个新的预后要素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/9606632/d9144055e8ab/cureus-0014-00000029637-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/9606632/d9144055e8ab/cureus-0014-00000029637-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/9606632/d9144055e8ab/cureus-0014-00000029637-i01.jpg

相似文献

1
Correlation of Tumor Budding With Known Clinicopathological, Histomorphological and Hormonal Receptor Status in Patients With Invasive Breast Carcinoma.浸润性乳腺癌患者肿瘤芽生与已知临床病理、组织形态学及激素受体状态的相关性
Cureus. 2022 Sep 26;14(9):e29637. doi: 10.7759/cureus.29637. eCollection 2022 Sep.
2
Tumor budding in invasive breast cancer - An indispensable budding touchstone.浸润性乳腺癌中的肿瘤芽生——一个不可或缺的芽生试金石。
Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S117-S122. doi: 10.4103/IJPM.IJPM_731_18.
3
Tumor budding in infiltrating breast carcinoma: Correlation with known clinicopathological parameters and hormone receptor status.浸润性乳腺癌中的肿瘤芽生:与已知临床病理参数及激素受体状态的相关性
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):222-225. doi: 10.4103/IJPM.IJPM_120_18.
4
Correlation of tumor budding with a novel and other established prognostic parameters in patients with invasive breast carcinoma.浸润性乳腺癌患者肿瘤芽生与一种新的及其他已确立的预后参数的相关性。
Indian J Pathol Microbiol. 2024 Oct 17. doi: 10.4103/ijpm.ijpm_920_23.
5
Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters.肿瘤芽生是浸润性导管癌患者死亡和转移的可靠预测指标,且与其他预后临床病理参数相关。
Ann Diagn Pathol. 2021 Oct;54:151792. doi: 10.1016/j.anndiagpath.2021.151792. Epub 2021 Jul 15.
6
Tumor budding in invasive breast carcinoma: correlation with clinicopathological parameters, hormone receptor status, and survival: an observational study.浸润性乳腺癌中的肿瘤芽生:与临床病理参数、激素受体状态和生存的相关性:一项观察性研究。
Rev Assoc Med Bras (1992). 2023 Sep 25;69(10):e20230191. doi: 10.1590/1806-9282.20230191. eCollection 2023.
7
A Retrospective Study of Association of Tumor Budding, Tumor Microenvironment, and Clinicopathological Characteristics of Invasive Breast Carcinoma.浸润性乳腺癌的肿瘤芽生、肿瘤微环境与临床病理特征相关性的回顾性研究
J Lab Physicians. 2022 Jun 10;14(4):485-490. doi: 10.1055/s-0042-1747676. eCollection 2022 Dec.
8
Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.肿瘤芽生与临床早期舌鳞状细胞癌的隐匿性颈淋巴结转移及不良预后相关。
J Oral Pathol Med. 2015 Apr;44(4):266-72. doi: 10.1111/jop.12242. Epub 2014 Aug 28.
9
Tumor Budding in Invasive Breast Carcinoma, No Special Type: Association With Pathological Prognostic Factors and Comparison of 2 Different Scoring Systems.浸润性乳腺癌,非特殊类型中的肿瘤芽生:与病理预后因素的关联及两种不同评分系统的比较
Int J Surg Pathol. 2025 Apr;33(2):309-317. doi: 10.1177/10668969241260213. Epub 2024 Jul 21.
10
Analyzing Tumor Budding Scores in Invasive Breast Carcinoma: A Tertiary Care Center Study in South India.分析浸润性乳腺癌中的肿瘤芽生评分:印度南部一家三级医疗中心的研究
J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1850-S1853. doi: 10.4103/jpbs.jpbs_910_23. Epub 2024 Apr 16.

引用本文的文献

1
Tumour Budding with Epithelial Mesenchymal Transition Markers - A Novel Prognostic Tool for Breast Carcinoma.具有上皮-间质转化标志物的肿瘤芽生——一种用于乳腺癌的新型预后工具。
J Midlife Health. 2025 Apr-Jun;16(2):186-191. doi: 10.4103/jmh.jmh_77_25. Epub 2025 Jun 23.
2
Tumor Budding: A Novel Prognostic Marker in Breast Carcinoma with Correlation of Histopathological and Immunohistochemical Parameters.肿瘤芽生:乳腺癌中的一种新型预后标志物及其与组织病理学和免疫组化参数的相关性
South Asian J Cancer. 2024 Aug 28;14(1):38-44. doi: 10.1055/s-0044-1789582. eCollection 2025 Jan.
3
Tumour budding in invasive ductal breast carcinomas: correlation with clinicopathological prognostic parameters and hormone receptor status.

本文引用的文献

1
Tumor budding in invasive breast cancer - An indispensable budding touchstone.浸润性乳腺癌中的肿瘤芽生——一个不可或缺的芽生试金石。
Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S117-S122. doi: 10.4103/IJPM.IJPM_731_18.
2
Tumor budding in infiltrating breast carcinoma: Correlation with known clinicopathological parameters and hormone receptor status.浸润性乳腺癌中的肿瘤芽生:与已知临床病理参数及激素受体状态的相关性
Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):222-225. doi: 10.4103/IJPM.IJPM_120_18.
3
Epidemiology of breast cancer in Indian women.
浸润性导管癌中的肿瘤芽生:与临床病理预后参数及激素受体状态的相关性
Pathol Oncol Res. 2025 Feb 12;31:1611983. doi: 10.3389/pore.2025.1611983. eCollection 2025.
4
Study of tumor budding and its association with clinicopathological parameters in breast carcinoma.研究肿瘤芽生及其与乳腺癌临床病理参数的关系。
Rev Assoc Med Bras (1992). 2024 Aug 16;70(7):e20240173. doi: 10.1590/1806-9282.20240173. eCollection 2024.
5
Tumor budding in invasive breast carcinoma: correlation with clinicopathological parameters, hormone receptor status, and survival: an observational study.浸润性乳腺癌中的肿瘤芽生:与临床病理参数、激素受体状态和生存的相关性:一项观察性研究。
Rev Assoc Med Bras (1992). 2023 Sep 25;69(10):e20230191. doi: 10.1590/1806-9282.20230191. eCollection 2023.
6
Correlation of Robinson's Cytological Grading with Elston and Ellis' Nottingham Modification of Bloom Richardson Score of Histopathology for Breast Carcinoma.罗宾逊细胞学分级与埃尔森和埃利斯对乳腺癌组织病理学布鲁姆-理查森评分的诺丁汉改良版之间的相关性。
Maedica (Bucur). 2023 Mar;18(1):55-60. doi: 10.26574/maedica.2023.18.1.55.
印度女性乳腺癌的流行病学
Asia Pac J Clin Oncol. 2017 Aug;13(4):289-295. doi: 10.1111/ajco.12661. Epub 2017 Feb 9.
4
The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.浸润性导管癌患者中肿瘤芽生、肿瘤微环境与生存之间的关系。
Br J Cancer. 2015 Sep 29;113(7):1066-74. doi: 10.1038/bjc.2015.287. Epub 2015 Aug 11.
5
High tumor budding stratifies breast cancer with metastatic properties.高肿瘤芽生可对具有转移特性的乳腺癌进行分层。
Breast Cancer Res Treat. 2015 Apr;150(2):363-71. doi: 10.1007/s10549-015-3333-3. Epub 2015 Mar 17.
6
The prognostic value of tumor budding in invasive breast cancer.肿瘤浸润前沿在浸润性乳腺癌中的预后价值。
Pathol Res Pract. 2013 May;209(5):269-75. doi: 10.1016/j.prp.2013.01.009. Epub 2013 Apr 3.
7
Tumor budding in colorectal carcinoma: time to take notice.结直肠癌中的肿瘤芽生:是时候引起重视了。
Mod Pathol. 2012 Oct;25(10):1315-25. doi: 10.1038/modpathol.2012.94. Epub 2012 Jul 13.
8
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.侵袭性结直肠癌中的上皮-间质转化与肿瘤芽生:肿瘤芽生作为肿瘤靶点
Oncotarget. 2010 Nov;1(7):651-61. doi: 10.18632/oncotarget.199.
9
Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?肿瘤细胞从局部破裂的肿瘤包膜中发芽:所有乳腺癌亚型浸润的常见途径?
J Cancer. 2010 Jun 2;1:32-7. doi: 10.7150/jca.1.32.
10
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌中人表皮生长因子受体2检测的指南建议
Arch Pathol Lab Med. 2007;131(1):18-43. doi: 10.5858/2007-131-18-ASOCCO.